000 01542 a2200457 4500
005 20250517000228.0
264 0 _c20150827
008 201508s 0 0 eng d
022 _a1179-1926
024 7 _a10.1007/s40262-014-0195-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHeuberger, Jules A A C
245 0 0 _aPopulation pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short- and long-term pharmacokinetics.
_h[electronic resource]
260 _bClinical pharmacokinetics
_cFeb 2015
300 _a209-19 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Inhalation
650 0 4 _aAdministration, Intravenous
650 0 4 _aAdministration, Oral
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aClinical Trials as Topic
650 0 4 _aComputer Simulation
650 0 4 _aDronabinol
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPsychotropic Drugs
_xadministration & dosage
650 0 4 _aYoung Adult
700 1 _aGuan, Zheng
700 1 _aOyetayo, Olubukayo-Opeyemi
700 1 _aKlumpers, Linda
700 1 _aMorrison, Paul D
700 1 _aBeumer, Tim L
700 1 _avan Gerven, Joop M A
700 1 _aCohen, Adam F
700 1 _aFreijer, Jan
773 0 _tClinical pharmacokinetics
_gvol. 54
_gno. 2
_gp. 209-19
856 4 0 _uhttps://doi.org/10.1007/s40262-014-0195-5
_zAvailable from publisher's website
999 _c24279690
_d24279690